Acquired cholesteatoma epithelial hyperproliferation: Roles of cell proliferation signal pathways
| Autor: | Xiaoli Wang, Wei Liu, Shumin Xie, Tuanfang Yin, Yuyan Xiang, Hongmiao Ren, Jihao Ren |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Pathology
medicine.medical_specialty Cell growth Cholesteatoma Biology medicine.disease 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Otorhinolaryngology chemistry 030220 oncology & carcinogenesis otorhinolaryngologic diseases Cancer research biology.protein STAT protein medicine Middle Ear Cholesteatoma Epidermal growth factor receptor Keratinocyte growth factor Signal transduction 030223 otorhinolaryngology Protein kinase B |
| Zdroj: | The Laryngoscope. 126:1923-1930 |
| ISSN: | 0023-852X |
| Popis: | Objectives/Hypothesis To review the recent cell proliferation signal pathways in the etiopathogenesis of acquired middle ear cholesteatoma. Data Sources PubMed (to September 2015). Review Methods Articles about cell proliferation signal pathways in the etiopathogenesis of acquired cholesteatoma and treatment advances were searched in the PubMed database, from which 73 were included in this review. Results The exact underlying cellular and molecular mechanism of acquired cholesteatoma still remains unknown. Recent research tends to regard the proliferation of cholesteatoma epithelial cells as the mechanism of cholesteatoma pathogenesis. Cell proliferation signal pathways including epidermal growth factor receptor/phosphoinositide 3-kinase/protein kinase B signal pathway, mitogen-activated protein kinase signal pathway, interleukin-6/signal transducer and activator of transcription 3 signal pathway, inhibitor of DNA binding/differentiation-1/nuclear factor-κB/cyclinD1 signal pathway, microRNA-mediated proliferation signal pathway, and keratinocyte growth factor/keratinocyte growth factor receptor signal pathway have been proven to play important roles in acquired middle ear cholesteatoma. Conclusions This review outlines the main biological properties of certain cell proliferation signal pathways, aiming to facilitate the development of potential therapeutic targets for intratympanic drug therapy for the nonsurgical or complementary treatment of cholesteatoma. Level of Evidence NA Laryngoscope, 126:1923–1930, 2016 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text